Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults
FranceStudy on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis
CzechiaStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
BulgariaStudy on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments
BulgariaStudy on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy
AustriaStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
AustriaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
BelgiumStudy on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis
BulgariaStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
